alzheimer's disease

UK Researchers Seek to Identify Ways to Relieve Post-Chemotherapy Cognitive Impairment

By Gail Hairston and Allison Perry

Of the 14 million cancer survivors in the United States, a significant number experience a serious side effect called chemotherapy-induced cognitive impairment (CICI). While easily recognized, little is known about the etiology of this condition, also known informally as “chemo brain.” CICI can significantly reduce patients’ quality of life with serious, even devastating, symptoms such as memory lapses, difficulty concentrating, negative impacts on multitasking, confusion and fatigue.

SACS - UK Chemistry Club Meeting

Date: 
Wednesday, March 11, 2015 - 5:30pm to 7:00pm
Location: 
CP-114

Butterfield's Research Garners International Recognition

Allan Butterfield describes his current project as "one of the most intellectually stimulating projects I've ever worked on."

Chemist Allan Butterfield Awarded Alkmeon International Prize for Alzheimer's Research

Butterfield is being awarded the Alkmeon International Prize for his contribution to research on Alzheimer's Disease in Rome on April 3rd.

UK's "Triple Crown" of Research Means Big Things for Kentucky

The University of Kentucky recently accomplished the “triple crown” of the academic medical world, earning three highly competitive grants and certifications.

Alzheimer's Researcher Lovell Named Gill Professor of Chemistry

Mark Lovell, a researcher for the University of Kentucky Sanders-Brown Center on Aging and a member of the faculty in the UK College of Arts and Sciences Department of Chemistry, has been named the Jack and Linda Gill Arts and Sciences Research Excellence Fund Professor in Chemistry.
Subscribe to RSS - alzheimer's disease
X
Enter your linkblue username.
Enter your linkblue password.
Secure Login

This login is SSL protected

Loading